Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$987M |
| 2 |
Salesforce
CRM
|
+$660M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$586M |
| 4 |
HCA Healthcare
HCA
|
+$513M |
| 5 |
Netflix
NFLX
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$815M |
| 2 |
Incyte
INCY
|
+$811M |
| 3 |
NVIDIA
NVDA
|
+$514M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$493M |
| 5 |
MetLife
MET
|
+$366M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.63% |
| 2 | Technology | 14.62% |
| 3 | Industrials | 7.94% |
| 4 | Healthcare | 7.93% |
| 5 | Energy | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AL
1251
DELISTED
Air Lease Corp
AL
| $16.6M | ﹤0.01% |
397,566
+29,923
| +8% | +$1.19M |
|
|
MDRX
1252
DELISTED
Veradigm Inc. Common Stock
MDRX
| $16.6M | ﹤0.01% |
1,319,746
+1,299
| +0.1% | +$15.8K |
|
1253
Entegris
ENTG
$24.6B
| $16.6M | ﹤0.01% |
150,044
-47,365
| -24% | -$4.32M |
|
1254
Integra LifeSciences
IART
$1.35B
| $16.6M | ﹤0.01% |
403,687
+15,987
| +4% | +$769K |
|
1255
Invesco S&P 500 High Beta ETF
SPHB
$956M
| $16.6M | ﹤0.01% |
217,172
+48,169
| +29% | +$3.35M |
|
1256
Darling Ingredients
DAR
$10B
| $16.6M | ﹤0.01% |
259,521
+9,181
| +4% | +$559K |
|
1257
Western Alliance Bancorporation
WAL
$8.92B
| $16.5M | ﹤0.01% |
453,737
+99,148
| +28% | +$3.44M |
|
1258
Teladoc Health
TDOC
$1.26B
| $16.5M | ﹤0.01% |
652,293
+311,421
| +91% | +$7.84M |
|
1259
Nuveen ESG Mid-Cap Value ETF
NUMV
$461M
| $16.5M | ﹤0.01% |
557,165
+2,914
| +0.5% | +$83K |
|
1260
Invesco S&P 500 Pure Value ETF
RPV
$1.74B
| $16.5M | ﹤0.01% |
212,710
-61,029
| -22% | -$4.56M |
|
1261
BioMarin Pharmaceuticals
BMRN
$13.6B
| $16.5M | ﹤0.01% |
190,229
-25,117
| -12% | -$2.36M |
|
1262
iShares US Regional Banks ETF
IAT
$689M
| $16.5M | ﹤0.01% |
487,136
+242,874
| +99% | +$8.16M |
|
1263
PUT
GE Aerospace
GE
$374B
| $16.5M | ﹤0.01% |
187,950
-137,830
| -42% | -$11.2M |
|
1264
Global X Uranium ETF
URA
$6.31B
| $16.4M | ﹤0.01% |
756,605
-207,673
| -22% | -$4.25M |
|
1265
CALL
Verizon
VZ
$200B
| $16.4M | ﹤0.01% |
441,400
+291,400
| +194% | +$10.8M |
|
|
BWIN
1266
Baldwin Insurance Group
BWIN
$3B
| $16.4M | ﹤0.01% |
661,906
+94,243
| +17% | +$2.23M |
|
1267
Glaukos
GKOS
$11.2B
| $16.4M | ﹤0.01% |
229,818
+12,843
| +6% | +$737K |
|
1268
Vanguard World Funds Extended Duration ETF
EDV
$3.49B
| $16.3M | ﹤0.01% |
187,489
+77,649
| +71% | +$6.77M |
|
1269
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.59B
| $16.3M | ﹤0.01% |
567,867
+154,358
| +37% | +$4.1M |
|
1270
Rithm Capital
RITM
$5.71B
| $16.3M | ﹤0.01% |
1,744,196
-40,201
| -2% | -$336K |
|
1271
Choice Hotels
CHH
$4.71B
| $16.3M | ﹤0.01% |
138,381
+108,600
| +365% | +$13M |
|
1272
Vermilion Energy
VET
$1.73B
| $16.2M | ﹤0.01% |
1,301,679
-47,260
| -4% | -$583K |
|
1273
CALL
AstraZeneca
AZN
$244B
| $16.2M | ﹤0.01% |
+113,200
| New | +$16.7M |
|
1274
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.6B
| $16.2M | ﹤0.01% |
416,527
+67,045
| +19% | +$2.49M |
|
|
AVNS
1275
DELISTED
Avanos Medical
AVNS
| $16.1M | ﹤0.01% |
630,809
+11,762
| +2% | +$310K |
|
Similar funds
Royal Bank of Canada's Q2 2023 Portfolio in Review
As of Q2 2023, Royal Bank of Canada held 8,037 positions worth $381B, up 7.7% from $354B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q2 2023 filing shows 676 new, 3,797 increased, 2,511 reduced and 409 closed positions. Its largest new stake was ATS Corp: 3,088,815 shares worth $142M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $815M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q2 2023 buy was ATS Corp: 3,088,815 shares worth $142M.
- Royal Bank of Canada added most to Thermo Fisher Scientific in Q2 2023, an estimated $987M increase.
- Royal Bank of Canada's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $815M.
- Royal Bank of Canada fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $150M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $381B portfolio in Q2 2023.
- Royal Bank of Canada opened 676 new positions and closed 409 in Q2 2023.
- Royal Bank of Canada's portfolio value rose 7.7% quarter-over-quarter to $381B.
Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.